Explore Shingrix - GSK
Search
Close this search box.

High-cost drugs amplify need for new reimbursement model

High-cost drugs amplify need for new reimbursement model | Picture of Specialty drug panelists, from left: Sandra Hanna, Neighbourhood Pharmacies; Alan Low, BioPro Biologics Pharmacy; Karen Chuk, McKesson Specialty Health; Chris Potter, Shoppers Drug Mart; Chris Dalseg, BioScript Solutions; Karl Frank, Bayshore Healthcare - The Canadian Foundation For Pharmacy

JANUARY 2020 – Service and not the cost of a drug needs to determine reimbursement levels for pharmacy, agreed participants in a panel discussion about specialty drugs at the Pharmacy Forum conference in November 2019, presented by the Canadian Foundation for Pharmacy. “It should not matter if a drug is $1 million or $100. To […]